Obesity is recognized as a chronic disease, making GLP-1 medications like semaglutide and tirzepatide eligible expenses under both account types
Purchase data shows GLP-1 users buying significantly more chicken, fresh meat, cheese, and yogurt, while cutting snacks, sugary drinks, and refined carbs
Our team is committed to providing personalized care tailored to each clients needs, ensuring they achieve their optimal health and aesthetic goals
This peptide has shown excellent safety profiles in animal studies with no lethal dose identified, though human clinical trial data remains limited
Only in-office injectables or fat grafting can truly address volume loss and rebuild facial structures
Its typical use level is 1-5% and has wide compatibility with other actives and oils